Walcker will oversee enterprise strategy, operations, and growth at The Specialty Alliance, while James Weber, MD, focuses on ...
Salma Patel, MD, shares findings from the implementation of combination therapy recommendations for patients with chronic ...
Standardized order sets, clinical team training on toxicity grading and treatment algorithms, and immediate access to ...
Alexander Spira, MD, PhD, medical oncologist at Virginia Cancer Specialists and chief scientific officer of NEXT Oncology, ...
Adam Spira, PhD, MA, discusses how composite measures of sleep health may offer a modifiable target to reduce dementia risk. Sleep is emerging as a powerful and multidimensional determinant of healthy ...
Phase 4 DUET enrolled adults with NT1/NT2 or idiopathic hypersomnia (ESS >10) and showed ≥2-point ESS reductions in 82% of narcolepsy and 95% of hypersomnia participants. Normal-range ESS (≤10) was ...
Three persistent barriers are preventing patients with obstructive sleep apnea (OSA) from receiving timely diagnosis and ...
Finding a new use for an approved therapy is always welcome news. Finding a use that improves outcomes for a condition where ...
Prolonged referral-to-testing workflows motivate using wearable-derived respiratory surrogates to triage suspected ...
Sunil Sharma, MD, discusses the consequences of not diagnosing patients with sleep-disordered breathing during hospital ...
Baseline QOL is an independent prognostic factor for survival in AML, with global QOL carrying the largest HR, according to ...
This analysis compared health care resource utilization and costs for Medicaid patients with serious mental illness between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results